Welcome to our dedicated page for Spectral AI SEC filings (Ticker: MDAIW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Spectral AI, Inc. (MDAIW) SEC filings page provides access to the company’s regulatory disclosures related to its Nasdaq-listed redeemable warrants and underlying business. Spectral AI identifies itself as a Dallas-based predictive AI company focused on medical diagnostics for wound care, with initial applications involving burn patients and the development of its DeepView System.
Through its filings, including current reports on Form 8-K, Spectral AI reports material events such as financial results, conference calls, and key regulatory milestones. For example, the company has filed 8-Ks describing the release of quarterly financial results and the submission of a De Novo request to the U.S. Food and Drug Administration for its DeepView System, intended for use in burn care settings including burn centers and emergency departments.
Filings also identify Spectral AI as an emerging growth company and list its securities, including redeemable warrants trading under the symbol MDAIW on The Nasdaq Stock Market LLC. These documents can provide details on warrant terms, such as each whole warrant being exercisable for one share of common stock at a specified exercise price, as well as information about the company’s address and status.
On Stock Titan, SEC documents for Spectral AI are paired with AI-powered summaries that highlight key points from lengthy filings. Users can quickly see what the company reports about its DeepView development, BARDA-supported activities, financial condition, and significant corporate events, while still having access to the full original filings from EDGAR for deeper review.
Hudson Bay Capital Management and Sander Gerber report a 7.80% beneficial stake in Spectral AI, Inc. common stock. They report beneficial ownership of 2,466,620 shares, including 939,904 shares issuable upon exercise of warrants, with shared voting and dispositive power over all reported shares.
The ownership percentage is calculated based on 30,688,895 Spectral AI common shares outstanding as of November 11, 2025, as disclosed in the company’s Form 10-Q. Certain warrants are subject to a 4.99% beneficial ownership blocker, and the reported ownership figures already reflect this limitation. The filers state the position is held in the ordinary course and not for the purpose of changing or influencing control.
Spectral AI, Inc. reported that its Board of Directors has appointed Vincent S. Capone as Chief Executive Officer, effective February 9, 2026, and dissolved the prior Office of the Chairman. Capone previously served as Chief Financial Officer since February 2024 and General Counsel since March 2022.
The company highlights his background in law, accounting, finance and operations, including experience at KPMG, major law firms and a private equity fund. Spectral AI notes this leadership change comes as it moves toward commercialization of its AI-driven DeepView System for burn wound assessment, following an FDA submission in June 2025.
Spectral AI, Inc. received a Schedule 13G/A reporting that Laurence E. Hirsch, Highlander Partners, L.P. and Highlander Partners GP, LLC each beneficially own 900,000 shares of the issuer's common stock, representing 3.50% of the outstanding class based on 25,737,820 shares stated outstanding as of June 30, 2025. The filing notes these holdings are comprised of common stock held by Highlander Partners, L.P., which were formerly held directly by Laurence E. Hirsch, and identifies Mr. Hirsch as sole manager of Highlander Partners GP, LLC. The filing clarifies voting and dispositive powers: Hirsch and Highlander Partners, L.P. report sole voting and dispositive power over 900,000 shares while Highlander Partners GP, LLC reports shared voting and dispositive power over the same amount. The schedule includes a joint filing agreement, an Item 8 statement, and a previously filed power of attorney.
Spectral AI reported its financial results for the quarter ended June 30, 2025 and furnished a press release as Exhibit 99.1 to this current report. The company also hosted an investor conference call to discuss the results, and a replay is available on the company website.
The filing notes that the press release and related materials are furnished and therefore are not deemed "filed" for purposes of Section 18 of the Exchange Act and are not incorporated by reference into other securities filings except as expressly specified. The 8-K lists Exhibit 99.1 and an Inline XBRL cover page; no detailed financial statements or tables are included in this document.